Security key
76090R309
ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS)
CUSIP: 76090R309
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 3,326,711
- Total 13F shares
- 19,112
- Share change
- +17,848
- Total reported value
- $85,238
- Price per share
- $4.46
- Number of holders
- 9
- Value change
- +$79,600
- Number of buys
- 4
- Number of sells
- 1
Report period
Q4 2024
Institutions
9
Top holders
10
RSLS full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Vyome Holdings, Inc SEC filings
Vyome Holdings, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76090R309
Recent filing periods:
Top shareholders of RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
665
|
$3,757 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.02%
|
588
|
$3,322 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4
|
$23 | — | 30 Sep 2024 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
2
|
$11 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
2
|
$11 | — | 30 Sep 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Sep 2024 | |
| ARMISTICE CAPITAL, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
14,446,692
|
$79,167,872 | — | 28 Jun 2021 | |
| Yair Schneid |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,461,000
|
$13,486,280 | — | 05 Jan 2024 | |
| Barton P. Bandy |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
773,098
|
$208,736 | — | 05 Aug 2022 | |
| Dan W. Gladney |
3/4/5
|
Director |
—
class O/S missing
|
283,922
|
$76,659 | — | 22 Jul 2021 | |
| Arda Minocherhomjee PhD |
3/4/5
|
Director |
—
class O/S missing
|
253,429
|
$68,426 | — | 22 Jul 2021 | |
| BLACKFORD GARY |
3/4/5
|
Director |
—
class O/S missing
|
253,429
|
$68,426 | — | 22 Jul 2021 | |
| Lori Courtney McDougal |
3/4/5
|
Director |
—
class O/S missing
|
253,429
|
$68,426 | — | 22 Jul 2021 | |
| Thomas Stankovich |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
45,726
|
$11,890 | — | 30 Nov 2023 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
—
class O/S missing
|
3
|
$18 | — | 30 Sep 2024 | |
| Planned Solutions, Inc. |
13F
|
Company |
—
class O/S missing
|
1
|
$6 | — | 30 Sep 2024 |
Institutional Holders of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) as of Q4 2024
As of 31 Dec 2024,
ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,112 shares.
The largest 10 holders included
UBS Group AG, Tower Research Capital LLC (TRC), BlackRock, Inc., BANK OF AMERICA CORP /DE/, DANSKE BANK A/S, GROUP ONE TRADING LLC, OSAIC HOLDINGS, INC., CIBC Private Wealth Group LLC, SBI Securities Co., Ltd., and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
8
Q4 2024 holders
9
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.